T*C
发帖数: 5492 | 1 Amgen (AMGN): Q2 EPS of $1.61 beats by $0.07. Revenue of $4.48B (+13% Y/Y)
beats by $400M. Shares +4.4% AH | T*C
发帖数: 5492 | 2 More on Amgen (AMGN): Q2 beats across the board on a 13% Y/Y jump in total
revenue. Product sales growth was driven by strong performance across the
portfolio. Xgeva sales total: $179M. For 2012, the company guides higher,
now seeing an EPS of $6.20 to $6.35 on revenue of $16.9B to $17.2B. Street
estimates are for earnings of $6.15 per share on $16.37B in revenue.
【在 T*C 的大作中提到】
: Amgen (AMGN): Q2 EPS of $1.61 beats by $0.07. Revenue of $4.48B (+13% Y/Y)
: beats by $400M. Shares +4.4% AH
|
|
